Anti-cancer drug for women weakens bone density
A drug tipped for widespread use to prevent breast cancer in post-menopausal women also accelerates loss of bone density, thus potentially boosting the risk of fractures, a study published on Tuesday said.
DEA raids 2 CVS pharmacies in drug abuse probe
ORLANDO, Florida (Reuters) - The Drug Enforcement Administration said on Monday it raided two CVS pharmacies over the weekend as part of an effort to curb the abuse of prescription painkillers and other potentially addictive substances. The action, which occurred on Saturday, came one day after the agency suspended the license of drug distributor Cardinal Health Inc, prohibiting it from shipping ...
FDA questions new use for Amgen drug
Amgen has asked the FDA to approve the injectable drug Xgeva as a preventive measure for men with recurring prostate cancer that is at high risk of spreading to the bone. Scientists for the Food and Drug Administration say that an Amgen Inc. drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side ...
FDA questions Amgen drug for prostate cancer
Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
FDA question's Amgen drug for prostate cancer
Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects.